نتایج جستجو برای: myeloid leukemia

تعداد نتایج: 302085  

Journal: :middle east journal of cancer 0
abolfazl movafagh department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran mehrdad hashemi associate professor of molecular genetics, department of genetics, islamic azad university,tehran medical branch,tehran,iran mojtaba ghadiani department of internal medicine/oncology, taleghani hospital, shahid beheshti university of medical sciences, tehran, iran reza mirfakhraei department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran hossein darvish department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran davood zare abdollahi department of medical genetics, school of medicine, shahid beheshti university of medical sciences, tehran, iran

background : according to the literature, there are a number of chronic and acute myeloid leukemias with unique, complex chromosome translocations. this study aims to conduct a brief review of the incidence of complex chromosome translocations in myeloid leukemia and reports a case of myeloid leukemia with complex chromosome translocations. methods :we conducted a web-based search for all peer ...

Journal: :international journal of hematology-oncology and stem cell research 0
shabnam shokouhi department of epidemiology, faculty of public health, ilam university of medical sciences, ilam, iran ; psychosocial injuries research center, ilam university of medical sciences, ilam, iran. sarah bray discipline of medicine, faculty of health sciences, university of adelaide, adelaide, south australia, australia ; department of hematology/oncology, basil hetzel institute for translational health research, the queen elizabeth hospital, woodville, south australia, australia. salar bakhtiyari department of clinical biochemistry, faculty of medicine, ilam university of medical sciences, ilam, iran. kourosh sayehmiri psychosocial injuries research center, ilam university of medical sciences, ilam, iran. kamran alimoghadam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran. ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.

background: allogeneic hematopoietic stem cell transplantation (hsct) is a curative treatment option for many patients with acute myeloid leukemia (aml); however, it can lead to complications of graft-versus-host-disease (gvhd) which can affect the quality of life and overall survival. the aim of this study was to assess the effects of both acute and chronic gvhd on survival rate in patients wi...

Journal: :international journal of hematology-oncology and stem cell research 0
thomas büchner dept. of medicine, hematology and oncology; university of münster, albert- schweitzer-str. 33, d-48129 münster; germany wolfgang hiddemann dept. of medicine, hematology and oncology; university of münster, albert- schweitzer-str. 33, d-48129 münster; germany wolfgang e berdel dept. of medicine, hematology and oncology; university of münster, albert- schweitzer-str. 33, d-48129 münster; germany bernhard wörmann dept. of medicine, hematology and oncology; university of münster, albert- schweitzer-str. 33, d-48129 münster; germany helmut löffler dept. of medicine, hematology and oncology; university of münster, albert- schweitzer-str. 33, d-48129 münster; germany claudia schoch dept. of medicine, hematology and oncology; university of münster, albert- schweitzer-str. 33, d-48129 münster; germany

intensive induction therapy-in acute myeloid leukemia (aml), as in some other systemic malignancies- is a strategy fundamentally different from post-remission strategies. approaches like consolidation treatment, prolonged mainte nance, and autologous or allogeneic transplantation in the first remission are directed against minimal residual disease with a malignant cell population having survive...

Journal: :iranian journal of blood and cancer 0
samin alavi mohammad taghi arzanian

background: the induction chemotherapy regimen for acute myeloid leukemia has evolved as once induction is completed patients progress through the consolidation phase and achieve remission in 76% of cases. for patients with relapsed or refractory disease, alternative chemotherapy agents are available. monoclonal antibody therapy with biological agents, such as the immunotoxin gemtuzumab ozogami...

Journal: :iranian journal of pediatric hematology and oncology 0
hossein ayatollahi department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univerسازمان های دیگر: cancer molecular pathology research center mohammad hadi sadeghian department of hematology and blood bank, faculty of medicine, cancer molecular pathology research center, mashhad univerسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)سازمان های دیگر: cancer molecular pathology research center sepideh shakeri cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) seyyede fatemeh shams cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) maryam sheikhi cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iran.سازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences) mohammad alidadi cancer molecular pathology research center, mashhad university of medical sciences, mashhad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی مشهد (mashhad university of medical sciences)

increment. it is categorized based on genetic aberrations. some of these genetic disorders can determine minimal residual diseases (mrd) and prognosis of aml patients. wilms tumor (wt1) over expression is found in aml patients. the aim of this study was to determine the frequency of wt1 over expression in aml pediatric cases in north -east of iran. materials and methods: this retrospective stud...

Bashir N, Bashir Y, Bhat Sh, Geelani S, Manzoor F, Rasool J,

Background: Acute Myeloid Leukemia (AML) with translocation (3,3) is a form of AML that may present de novo or may arise from a previous myelodysplastic syndrome. It is often associated with normal or elevated peripheral blood platelet count and increased bone marrow megakaryocytes with associated multi lineage dysplasia. A subset of patients present with hepatosplenomegaly while a few cases h...

Ali Akbar Movassaghpour Akbari, Nosrat Abedpor, Zohreh Sanaat,

Background: Acute myeloid leukemia (AML) is blood and bone marrow malignancy. Low-density oxidative lipoprotein (oxLDL) is a pro-inflammatory factor that has free radicals in its structure. OxLDL levels are also rising in diseases such as diabetes, cardiovascular disease, and some cancers. Studies have shown that oxLDL and dyslipidemia are more common in patients with various cancers. This stud...

Journal: :modares journal of medical sciences: pathobiology 2007
behjat gholami majid sadeghizadeh hossein najmabadi

objective: chronic myeloid leukemia (cml) is a malignant clonal disorder of hematopoietic stem cells which results in increase of myeloid cells, erythroid cells and platelets in the peripheral blood and hyperplasia in bone marrow. investigations have shown different types of bcr- abl variants in these patients. in iran only 3 types of these variants have been identified because most of the clin...

Journal: :basic and clinical cancer research 0
abolghasem allahyari department of hematology and medical oncology, mashhad university of medical sciences, mashhad, iran nazanin jalalian students research committee, mashhad university of medical sciences, mashhad, iran foad faroughi students research committee, mashhad university of medical sciences, mashhad, iran masoud sadeghi medical biology research center, kermanshah university of medical sciences, kermanshah, iran

background : acute myeloid leukemia (aml) is a disease in elderly patients, with a mean age of diagnosis of 70 years. we have analyzed the clinicopathology features and experimental variables in aml patients in eastern iran and the correlation between survival and fab subgroups of aml. materials and methods : during 2009 to 2014 in a retrospective study, 98 patients with aml referred to the cli...

Journal: :iranian journal of pediatric hematology and oncology 0
r masoumi-dehshiri nutrition and food security research centre, shahid sadoughi university of medical sciences, yazd, iran as hashemi hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) h neamatzadeh hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences) h zare-zardini hematology and oncology research center, shahid sadoughi university of medical sciences and health services, yazd, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شهید صدوقی یزد (shahid sadooghi university of medical sciences)

acute myeloid leukemia (aml-m7) is a type of pediatric aml accounting for 3–10% of primary childhood aml and children may present with a broad variety of symptoms including low-grade fever, diarrhea, easy bruising, failure to gain weight and life-threatening conditions. we report a rare case of aml .a 26-month-old boy who presented with weakness and fatigue. he was diagnosed as a case of amlm-7...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید